Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Idaho Sci-Tech Network.
October 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 |
November 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | |||||
| 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| 10 | 11 | 12 | 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 | 21 | 22 | 23 |
| 24 | 25 | 26 | 27 | 28 | 29 | 30 |
December 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 |
Press releases published on September 22, 2025
September 22, 2025
FOXO TECHNOLOGIES INC. ANNOUNCES CLOSING OF VECTOR BIOSOURCE INC. ACQUISITION
Indeterminate
GlobeNewswire
September 22, 2025
Biognosys to Launch Metabolomics/Lipidomics Services for Multiomics Drug Discovery and Clinical Research
Indeterminate
GlobeNewswire
September 22, 2025
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ESMO 2025
Indeterminate
GlobeNewswire
September 22, 2025
Beyond Air to Participate in the ROTH 4th Annual Healthcare Opportunities Conference
Indeterminate
GlobeNewswire
September 22, 2025
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
Indeterminate
GlobeNewswire
September 22, 2025
Idebenone Accepted by FDA for Priority Review for Leber Hereditary Optic Neuropathy (LHON)
Indeterminate
GlobeNewswire
September 22, 2025
ORYZON to Sponsor First Phelan-McDermid Syndrome (PMS) Burden of Illness Study
Indeterminate
GlobeNewswire
September 22, 2025
Connect Names Gretel von Son as Chief Operating Officer to Drive Growth in Entrepreneurship and Innovation
Indeterminate
GlobeNewswire
September 22, 2025
Grace Therapeutics Pivotal Phase 3 STRIVE-ON Safety Trial Presented at 2025 Neurocritical Care Annual Meeting
Indeterminate
GlobeNewswire
September 22, 2025
MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
Indeterminate
GlobeNewswire
September 22, 2025
Voltus Ranked #1 Aggregator in GW Under Management and C&I Programs in Wood Mackenzie’s 2025 VPP Report
Indeterminate
GlobeNewswire
September 22, 2025
Advent Technologies Delivers State-of-the-Art Portable Fuel Cell Systems under Contract with the U.S. Department of Defense
Indeterminate
GlobeNewswire
September 22, 2025
CEA Industries Board Authorizes $250 Million Stock Buyback Program
Indeterminate
GlobeNewswire